Simplex Trading’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History
Bought
Maintained
Sold
Other funds holding IDNA
WBG
PGA
Simplex Trading's IDNA Position: Q3 2025 in Review
Simplex Trading sold out of iShares Genomics Immunology and Healthcare ETF (IDNA) in Q3 2025, closing a stake of 241 shares — an estimated $4K sold.
Simplex Trading first reported a position in IDNA in Q2 2020 and held it in 15 quarters. The position peaked at $55K in Q3 2021. 51 funds tracked by Wall St. Rank hold IDNA as of Q3 2025.
- Simplex Trading reported no remaining iShares Genomics Immunology and Healthcare ETF position as of Q3 2025 after selling out during the quarter.
- Simplex Trading sold 241 iShares Genomics Immunology and Healthcare ETF shares in Q3 2025, an estimated $4K.
- Simplex Trading first reported a position in iShares Genomics Immunology and Healthcare ETF in Q2 2020 and held it in 15 quarters.
- Simplex Trading's iShares Genomics Immunology and Healthcare ETF position peaked at $55K in Q3 2021.
- 51 funds tracked by Wall St. Rank held iShares Genomics Immunology and Healthcare ETF as of Q3 2025.
Based on Simplex Trading's 13F filing for Q3 2025, filed 12 Nov 2025.